Andrew M. Wardley, Xavier B. Pivot, Flavia Morales-Vasquez, Luis M. Zetina, Maria de Fátima Dias Gaui, et al.. Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer..
Journal of Clinical Oncology, American Society of Clinical Oncology, 2010, 28 (6), pp.976-83.
⟨10.1200/JCO.2008.21.6531⟩.
⟨inserm-00484605⟩